GlassScriptPhysician profile
Ena K Osterhouse
NPI 1396129490
$5,590.00
in general payments reported to CMS, 2019-2025
6 companies · $679 in 2025
The $679 reported for 2025 was more than what 77% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,292 · 2022: $1,701 · 2023: $1,711 · 2024: $206 · 2025: $679.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,343 · Travel and Lodging: $1,254.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,343.23 |
| Travel and Lodging | $1,253.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Atricure, INC. | $3,363.86 | 2021-2025 | Atricure Cryoice Cryoablation System (Cryo2), Synergy Ablation System, Atriclip Laa Exclusion System |
| Intuitive Surgical, INC. | $1,635.04 | 2022 | |
| Edwards Lifesciences Corporation | $445.70 | 2021-2025 | Inspiris Resilia Aortic Valve, Mitris Resilia Mitral Valve, Sapien 3 Ultra Resilia |
| Galderma Laboratories, L.P. | $93.85 | 2024-2025 | |
| Novo Nordisk INC | $36.06 | 2025 | Wegovy |
| La Jolla Pharmaceutical Company | $15.49 | 2024 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ena Osterhouse listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.